Akebia Therapeutics, Inc. · NASDAQ:AKBA
State Street Corp reported a 5.20% stake in Akebia Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 5.20% stake in Akebia Therapeutics, Inc., 13,687,561 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 13,687,561
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.20% | 13,687,561 |
Source
Related
- Akebia Therapeutics, Inc.
- State Street Corp
- Akebia Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · May 12, 2026
- Form 4 · Butler John P. · Aug 10, 2026
- Form 4 · Ostrowski Erik · Jul 1, 2026
- Form 4 · Wolf Myles · Jun 22, 2026
- Form 4 · Smith Cynthia · Jun 22, 2026
- Form 4 · Rogers Michael W · Jun 22, 2026